about
Hemoglobin variants: biochemical properties and clinical correlatesIron deficiency anemia: a common and curable diseaseThe prevalence of thalassemia in mainland China: evidence from epidemiological surveysGenetic epidemiology and preventive healthcare in multiethnic societies: the hemoglobinopathies.Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.High prevalence of thalassemia in migrant populations in Guangdong Province, ChinaA genetic score for the prediction of beta-thalassemia severity.Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCsGuidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.Medium-based noninvasive preimplantation genetic diagnosis for human α-thalassemias-SEADevelopment of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean PopulationsThalassemia in the United Arab Emirates: Why it can be prevented but not eradicatedMutation screening for thalassaemia in the Jino ethnic minority population of Yunnan Province, Southwest China.Thalassemia and sickle cell anemia in Swedish immigrants: Genetic diseases have become global.Management of the thalassemiasThe Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.Prevalence of Thalassemia Trait & Iron Deficiency Anemia during Infancy in 2011-2013 in a Thalassemia Prevalent Region: North Cyprus.Human genome editing as a tool to establish causalityβ-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.β-Thalassemia Intermedia: A Bird's-Eye View.Thalassemias and hemoglobinopathies in Turkey.Sonographic markers of fetal α-thalassemia major.Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives.Thalassemia 2016: Modern medicine battles an ancient disease.The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy.Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.Hb A1c Determination by Capillary Electrophoresis is an Efficient Method for Detecting β-Thalassemias and Hemoglobin Variants.The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population.Analysis of Fetal Blood: Is There Still a Role for Prenatal Diagnosis of Thalassemia?Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies.Carrier Screening: Past, Present, and Future.Association of Tissue-Specific DNA Methylation Alterations with α-Thalassemia Southeast Asian Deletion.Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China.Effect of health education on severe thalassemia prevention and control in communities in Cambodia.Prevalence of β-thalassemia trait and abnormal hemoglobins in Sanliurfa Province in southeast Turkey.From Prenatal to Preimplantation Genetic Diagnosis of β-Thalassemia. Prevention Model in 8748 Cases: 40 Years of Single Center Experience.Prenatal detection of thalassemia by cell-free fetal DNA (cffDNA) in maternal plasma using surface enhanced Raman spectroscopy combined with PCR.
P2860
Q28285079-9B8B1715-5051-4ED9-978A-34D713917FFCQ28681312-4440A44A-87EF-4C1C-889F-011BBEF0F630Q33680932-67216CDD-014D-48A1-AC05-9B95DCE22FA0Q33833974-312BE7A2-7FDA-40FD-82B9-A0BDEE420CB3Q34153816-76432274-2055-4BDA-A448-416B5FE7041AQ34169004-04A3CB86-9773-4BAC-A02F-0C545EB6D1D5Q35236041-9CA12333-3C5F-4DD9-8888-ADCB6F35437CQ35834273-D40EB70C-5424-48E6-88A2-4B130C57ACEFQ35881019-612C1D05-7726-4CB2-A314-E752CE380EB6Q36009063-E812C7B6-56E2-4B8E-97B3-66F8461B8157Q36063204-C5A0D81F-13ED-4C9E-8AB9-205BAF02AA69Q36263885-7B22026A-32A0-4968-809F-2AEB49AB93CEQ36456857-6FB6EE69-512E-4186-92F8-6357C7459D0DQ36766450-BD2A3645-06AA-41E5-84F2-58F5AD3EEB9FQ36870253-97FF89F2-57FF-400C-9360-AB849AA2A3FEQ37223455-0EA5EFF3-66DB-4823-A162-3BFA02FF74E4Q37478070-BB97258E-7EF6-4740-89F2-744BB992CF38Q37543764-E89B9B57-545E-4551-816A-EECE0B0B13DFQ37677224-3CDA03F6-4ACD-4A5F-86EA-595C80F6B07CQ37718392-DC0FBE76-BA4E-49CA-B693-2FB258B1DF17Q38230209-58D5B24B-D101-4772-8110-7E1574D95AE2Q38329587-0542B8BE-1CE9-4D68-9606-A52F4FBCA2FFQ38374011-3AACA045-85EC-407C-86BC-7D44B52AFC89Q38625435-34B89E93-4C3E-4A9C-ADF2-85E4EB61CC5DQ38865359-C4ECE862-6AC6-4D21-8973-B9649427B188Q39026510-444F6D09-EC07-48C0-889E-4D4055458B7CQ39480320-A882C3E5-C0C9-48D8-8C20-2F18F7C9DC2DQ40008183-8D6FEC60-D912-4941-836E-052C3885BDA5Q41118912-6DEEEBFB-F96A-4C96-8477-78216D5E67CAQ41688378-A2BAF120-A132-4AAA-9FC8-50A9BE88C6BEQ46330110-88309727-02E7-408D-8EDC-50C95F09AA67Q47159911-426D5492-9743-45F7-826E-DDDBEF06FFF3Q48308804-9C883043-CF71-44C3-9DC9-F016999AAD6BQ50282280-904E5424-1289-4980-929B-D4DD42351CCBQ50456978-2A8649CD-10B3-4032-95AB-8B7888429403Q54096952-9CFD1752-81BB-425C-ABB3-6BD3060479ACQ55424946-373F57B3-C246-4B52-87A7-434053B2066A
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The prevention of thalassemia.
@ast
The prevention of thalassemia.
@en
type
label
The prevention of thalassemia.
@ast
The prevention of thalassemia.
@en
prefLabel
The prevention of thalassemia.
@ast
The prevention of thalassemia.
@en
P2860
P1476
The prevention of thalassemia.
@en
P2093
Antonio Cao
Yuet Wai Kan
P2860
P304
P356
10.1101/CSHPERSPECT.A011775
P577
2013-02-01T00:00:00Z